PAYNE JOHN BERNARD
President and CEO
PAYNE JOHN BERNARD has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.
On the most recent filing, PAYNE JOHN BERNARD is listed as President and CEO at Zivo Bioscience, Inc. Inside the rolling window, PAYNE JOHN BERNARD reported 1 open-market purchase totaling $100K in ZIVO and no open-market sales.
Companies traded
Other insiders at ZIVO
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has PAYNE JOHN BERNARD made?
PAYNE JOHN BERNARD has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does PAYNE JOHN BERNARD trade?
PAYNE JOHN BERNARD has filed SEC Form 4 disclosures for 1 company, including ZIVO.
When was PAYNE JOHN BERNARD's most recent SEC Form 4 filing?
PAYNE JOHN BERNARD's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.
What is PAYNE JOHN BERNARD's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, PAYNE JOHN BERNARD is listed as President and CEO.
What is PAYNE JOHN BERNARD's total buy and sell value in the current window?
Inside the rolling retention window, PAYNE JOHN BERNARD bought $100K and sold $0 based on SEC Form 4 filings.
What was PAYNE JOHN BERNARD's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 11,709 ZIVO shares on 2026-01-26, worth $100K, per SEC Form 4 filings.